Your browser doesn't support javascript.
loading
Safety, Antitumor Activity, and T-cell Responses in a Dose-Ranging Phase I Trial of the Oncolytic Peptide LTX-315 in Patients with Solid Tumors.
Spicer, James; Marabelle, Aurélien; Baurain, Jean-Francois; Jebsen, Nina Louise; Jøssang, Dag Erik; Awada, Ahmad; Kristeleit, Rebecca; Loirat, Delphine; Lazaridis, George; Jungels, Christiane; Brunsvig, Paal; Nicolaisen, Berit; Saunders, Andrew; Patel, Hamina; Galon, Jérôme; Hermitte, Fabienne; Camilio, Ketil André; Mauseth, Brynjar; Sundvold, Vibeke; Sveinbjørnsson, Baldur; Rekdal, Øystein.
Afiliación
  • Spicer J; King's College London, Guy's Hospital, United Kingdom. james.spicer@kcl.ac.uk.
  • Marabelle A; DITEP, INSERM U1015 & CIC1428, Université Paris Saclay, Gustave Roussy, France.
  • Baurain JF; Cliniques Universitaires Saint-Luc, Louvain, Belgium.
  • Jebsen NL; Centre for Cancer Biomarkers, University of Bergen, Bergen, Norway.
  • Jøssang DE; Haukeland University Hospital, Bergen, Norway.
  • Awada A; Haukeland University Hospital, Bergen, Norway.
  • Kristeleit R; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
  • Loirat D; University College London Hospital, London, United Kingdom.
  • Lazaridis G; Institut Curie, Paris, France.
  • Jungels C; King's College London, Guy's Hospital, United Kingdom.
  • Brunsvig P; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
  • Nicolaisen B; Oslo University Hospital, Oslo, Norway.
  • Saunders A; Lytix Biopharma, Oslo, Norway.
  • Patel H; Lytix Biopharma, Oslo, Norway.
  • Galon J; Lytix Biopharma, Oslo, Norway.
  • Hermitte F; INSERM Laboratory of Integrative Cancer Immunology, Paris, France.
  • Camilio KA; HalioDX, Marseille, France.
  • Mauseth B; Lytix Biopharma, Oslo, Norway.
  • Sundvold V; Lytix Biopharma, Oslo, Norway.
  • Sveinbjørnsson B; Lytix Biopharma, Oslo, Norway.
  • Rekdal Ø; Lytix Biopharma, Oslo, Norway.
Clin Cancer Res ; 27(10): 2755-2763, 2021 05 15.
Article en En | MEDLINE | ID: mdl-33542073
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oligopéptidos / Linfocitos T / Neoplasias / Antineoplásicos Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oligopéptidos / Linfocitos T / Neoplasias / Antineoplásicos Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos